(19)
(11) EP 4 770 987 A1

(12)

(43) Date of publication:
08.07.2026 Bulletin 2026/28

(21) Application number: 24776059.8

(22) Date of filing: 28.08.2024
(51) International Patent Classification (IPC): 
C07C 55/08(2006.01)
C07C 215/34(2006.01)
A61P 37/08(2006.01)
(52) Cooperative Patent Classification (CPC):
C07C 215/34; C07C 55/08; C07B 2200/13; A61P 37/08
(86) International application number:
PCT/US2024/044275
(87) International publication number:
WO 2025/049636 (06.03.2025 Gazette 2025/10)
(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC ME MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated Extension States:
BA
Designated Validation States:
GE KH MA MD TN

(30) Priority: 29.08.2023 US 202363535184 P
02.04.2024 US 202463573095 P

(71) Applicant: Biothea Pharma, Inc.
Boston, MA 02111 (US)

(72) Inventors:
  • SOMMADOSSI, Jean-Pierre
    Boston, Massachusetts 02110 (US)
  • MOUSSA, Adel
    Burlington, Massachusetts 01803 (US)

(74) Representative: Schlich 
9 St Catherine's Road Littlehampton
West Sussex BN17 5HS
West Sussex BN17 5HS (GB)

   


(54) POLYMORPHIC FORMS OF EPINEPHRINE MALONATE